Exane Derivatives’s UBS Group UBS Stock Holding History

Exane Derivatives’s Portfolio UBS Stock Details UBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,104	Closed	-$664K	–	1012
2021 Q3	$664K	Sell	14,104 -439	-3%	-$7.11K	0.16%	138
2021 Q2	$742K	Sell	14,543 -8,083	-36%	-$128K	0.17%	118
2021 Q1	$1.82M	Buy	22,626 +9,642	+74%	+$148K	0.52%	40
2020 Q4	$3.37M	Sell	12,984 -33,530	-72%	-$444K	0.99%	21
2020 Q3	$11.7M	Sell	46,514 -2,120	-4%	-$25.4K	3.38%	3
2020 Q2	$9.88M	Sell	48,634 -27,938	-36%	-$288K	2.64%	4
2020 Q1	$22.1M	Sell	76,572 -5,514	-7%	-$63.5K	6.17%	2
2019 Q4	$7.43M	Sell	82,086 -17,151	-17%	-$204K	1.38%	13
2019 Q3	$14.5M	Buy	99,237 +27,314	+38%	+$307K	2.6%	6
2019 Q2	$12M	Sell	71,923 -11,216	-13%	-$137K	2.1%	8
2019 Q1	$16.1M	Buy	83,139 +11,217	+16%	+$142K	3.18%	3
2018 Q4	$16M	Sell	71,922 -22,378	-24%	-$304K	2.87%	5
2018 Q3	$7.44M	Buy	94,300 +2,778	+3%	+$43.7K	1.4%	12
2018 Q2	$14.1M	Buy	91,522 +10,205	+13%	+$166K	2.35%	9
2018 Q1	$7.99M	Buy	81,317 +18,027	+28%	+$343K	1.6%	10
2017 Q4	$4.81M	Sell	63,290 -17,798	-22%	-$309K	0.83%	19
2017 Q3	$6.99M	Buy	81,088 +32,817	+68%	+$561K	1.31%	13
2017 Q2	$5.34M	Buy	48,271 +3,709	+8%	+$60.3K	1.15%	16
2017 Q1	$3.13M	Buy	44,562 +559	+1%	+$9K	0.71%	34
2016 Q4	$4.32M	Sell	44,003 -22,037	-33%	-$332K	0.85%	18
2016 Q3	$17.7M	Buy	+66,040	New	+$899K	2.66%	4
2016 Q2	–	Sell	-51,130	Closed	-$16.4M	–	626
2016 Q1	$16.4M	Buy	51,130 +11,432	+29%	+$186K	2.17%	3
2015 Q4	$5.33M	Buy	39,698 +4,917	+14%	+$95.9K	0.73%	40
2015 Q3	$7.49M	Sell	34,781 -16,906	-33%	-$358K	0.95%	36
2015 Q2	$4.07M	Buy	51,687 +10,499	+25%	+$219K	0.44%	49
2015 Q1	$8.26M	Buy	41,188 +590	+1%	+$10.3K	0.91%	37
2014 Q4	$9.57M	Buy	+40,598	New	+$695K	1.33%	34

Other funds holding UBS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Exane Derivatives's UBS Position: Q2 2022 in Review

Exane Derivatives reduced its UBS Group (UBS) stake by 49% in Q2 2022, selling an estimated $384K and leaving 22,455 shares worth $360K. The position accounts for 0.21% of the portfolio, ranked #118.

Exane Derivatives first reported a position in UBS in Q4 2014 and has held it in 25 quarters since. The position peaked at $68.1M in Q3 2017. 368 funds tracked by Wall St. Rank hold UBS as of Q2 2022.

Exane Derivatives held 22,455 shares of UBS Group worth $360K as of Q2 2022.
Exane Derivatives sold 21,925 UBS Group shares in Q2 2022, an estimated $384K.
UBS Group made up 0.21% of Exane Derivatives's portfolio in Q2 2022, its #118 holding.
Exane Derivatives first reported a position in UBS Group in Q4 2014 and has held it in 25 quarters since.
Exane Derivatives's UBS Group position peaked at $68.1M in Q3 2017.
368 funds tracked by Wall St. Rank held UBS Group as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.